More safety issues with fast-tracked drugs

Among 434 new agents approved by Health Canada from 1995 to 2010, those approved in a standard 300-day review had a one in five chance of earning a safety warning or of being withdrawn while those fast-tracked in 180 days had more than a one in three chance of such an outcome.
Arch Intern Med 2012; online 8 Oct